Search Results - Elkas, J.C

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Interim analysis of a phase I/IIA trial assessing E39 + GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients

    Interim analysis of a phase I/IIA trial assessing E39 + GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients by Maxwell, G.L, Elkas, J.C, Conrads, T.P, Darcy, K.M, Hamilton, C.A, Peoples, G

    Published in Gynecologic oncology
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    2764 Preliminary results of the phase I/IIa dose finding trial of a folate binding protein vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence

    2764 Preliminary results of the phase I/IIa dose finding trial of a folate binding protein vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence by Greene, J.M, Schneble, E.J, Berry, J.S, Trappey, A.F, Clifton, G.T, Darcy, K, Elkas, J.C, Hamilton, C.A, Maxwell, G.L, Peoples, G.E

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Phase I trial results of a folate receptor alpha-directed cancer vaccine (E39) in ovarian and endometrial cancer patients to prevent recurrence

    Phase I trial results of a folate receptor alpha-directed cancer vaccine (E39) in ovarian and endometrial cancer patients to prevent recurrence by Schneble, E, Ponniah, S, McGuire, W.P, Conrads, T.P, Elkas, J.C, Darcy, K.M, Maxwell, G.L, Hamilton, C.A, Peoples, G

    Published in Gynecologic oncology
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: